Symbol="SQZ"
AssetType="Common Stock"
Name="Sqz BiotechnologiesÂ Co"
Description="SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. The company is headquartered in Watertown, Massachusetts."
CIK="1604477"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 ARSENAL YARDS BLVD., STE. 210, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="12828600"
EBITDA="-71585000"
PERatio="None"
PEGRatio="None"
BookValue="1.362"
DividendPerShare="0"
DividendYield="0"
EPS="-2.16"
RevenuePerShareTTM="0.638"
ProfitMargin="0"
OperatingMarginTTM="-3.924"
ReturnOnAssetsTTM="-0.333"
ReturnOnEquityTTM="-1.049"
RevenueTTM="18609000"
GrossProfitTTM="-43050000"
DilutedEPSTTM="-2.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.033"
AnalystTargetPrice="19"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.244"
PriceToBookRatio="0.498"
EVToRevenue="0.579"
EVToEBITDA="-0.183"
Beta="2.707"
num_52WeekHigh="35.6"
num_52WeekLow="0.132"
num_50DayMovingAverage="0.509"
num_200DayMovingAverage="1.134"
SharesOutstanding="29491100"
DividendDate="None"
ExDividendDate="None"
symbol="SQZ"
open="0.19"
high="0.20"
low="0.14"
price="0.16"
volume="113503.00"
latest_trading_day="2023-07-14"
previous_close="0.17"
change="-0.01"
change_percent="-5.9377%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="93"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="7"
Volume_recent_avg="594870"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-2.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="7"
Aroon_momentum_negative="93"
image_negative_thumbnail_id_1="1165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_negative_thumbnail_id_2="1110"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_neutral_thumbnail_id_1="579"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="615"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_positive_thumbnail_id_2="658"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
